- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 21/06 - Anabolic agents
Patent holdings for IPC class A61P 21/06
Total number of patents in this class: 402
10-year publication summary
|
11
|
12
|
16
|
13
|
28
|
58
|
40
|
26
|
22
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acceleron Pharma Inc. | 358 |
16 |
| Société des Produits Nestlé S.A. | 9339 |
14 |
| Scholar Rock, Inc. | 120 |
11 |
| Nestec S.A. | 2647 |
8 |
| Regeneron Pharmaceuticals, Inc. | 4362 |
8 |
| Sorbonne Universite | 1313 |
8 |
| N.V. Nutricia | 1064 |
7 |
| Avidity Biosciences, Inc. | 162 |
7 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3368 |
6 |
| TdeltaS Limited | 104 |
6 |
| Association Institut de Myologie | 116 |
5 |
| Abbott Laboratories | 2397 |
4 |
| Centre National de La Recherche Scientifique | 10576 |
4 |
| Massachusetts Institute of Technology | 10117 |
4 |
| President and Fellows of Harvard College | 6005 |
4 |
| Biophytis | 35 |
4 |
| Meiji Co., Ltd. | 734 |
4 |
| Monash University | 715 |
4 |
| Novartis AG | 10709 |
3 |
| The Regents of the University of California | 20137 |
3 |
| Other owners | 272 |